HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Sporotrichosis — Clinical Guidelines

Overview

Sporotrichosis is a fungal infection caused by Sporothrix species, predominantly Sporothrix brasiliensis, characterized by cutaneous and potentially disseminated lesions, often following traumatic inoculation. 1

Diagnosis

Clinical Presentation: Typically begins with localized skin lesions (lymphocutaneous type) progressing along lymphatic channels; disseminated forms can present with systemic symptoms and widespread cutaneous lesions 1 2.

Microbiological Tests: Histopathology with periodic acid-Schiff (PAS) staining or Gomori methenamine silver (GMS) stain; culture of clinical specimens (lesional tissue, pus, or exudates) on Sabouraud dextrose agar 1.

Molecular Diagnostics: PCR testing can aid in rapid diagnosis 1.

Differential Diagnosis: Important to rule out other chronic skin infections like tuberculosis, leishmaniasis, and other fungal infections, especially in disseminated cases mimicking venous ulcers 2.

Management

First-Line Treatment:

- Amphotericin B: Intravenous for severe or disseminated cases (dose varies; consult specific guidelines) 1. - Itraconazole: Oral, typically 200-400 mg/day for localized cutaneous sporotrichosis 1.

Adjunctive Treatments:

- Terbinafine: Oral, 250-500 mg/day, may be used in combination for refractory cases 1. - Surgical Intervention: Debridement or excision of necrotic tissue in severe cases 1.

Special Populations

Immunocompromised Patients: More prone to disseminated disease; require aggressive systemic antifungal therapy (e.g., amphotericin B) 2.

Pregnancy: Limited data; itraconazole is often considered safe but close monitoring is advised 1.

Key Recommendations

Clinical Classification: Implement a standardized clinical classification system for sporotrichosis to guide management decisions (Evidence: Moderate) 1.

Diagnostic Approach: Utilize histopathology and culture for definitive diagnosis, supplemented by molecular methods when available (Evidence: Moderate) 1.

Treatment Initiation: Initiate systemic antifungal therapy with itraconazole for localized cutaneous sporotrichosis and consider amphotericin B for severe or disseminated cases (Evidence: Moderate) 1.

Monitoring Immunocompromised Patients: Closely monitor and treat immunosuppressed individuals with aggressive systemic antifungals due to higher risk of dissemination (Evidence: Expert opinion) 2.

References

1 Orofino-Costa R, Freitas DFS, Bernardes-Engemann AR, Rodrigues AM, Talhari C, Ferraz CE et al.. Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management. Anais brasileiros de dermatologia 2022. link 2 Alvarez-Rivero V, Hernandez-Castro R, Moreno-Coutiño G, Lozano-Platonoff A. Disseminated Sporotrichosis: An Important Differential Diagnosis for Venous Ulcers. Advances in skin & wound care 2020. link 3 Furfaro T. Sporotrichosis. Dermatology nursing 2002. link

Sporotrichosis